Preventing Mother-to-child Transmission of Hepatitis B Virus With Tenofovir Alafenamide (TAF)

NCT05177926 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

330

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis B, Chronic
Mother to Child Transmission

Interventions

DRUG: antiviral prophylaxis with Tenofovir Alafenamide Fumarate

Sponsor

Nanfang Hospital, Southern Medical University

Collaborators

[object Object]
[object Object]